Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

[Progress in virus-like particles technique studies].

Jian-Qiang Guo¹, Zhi-Qing Zhang

¹State Key Laboratory for Molecular Virology and Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China.

Zhongguo Yi Miao He Mian Yi

|January 19, 2010

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

MYDGF promotes pathological and physiological retinal angiogenesis via the Gαi1/3-Gab1-Akt-mTOR signaling.

Nature communications·2026

Same author

The protein RAB5IF promotes BDNF signaling by stimulating the SUMOylation of Gα<sub>i1/3</sub> to reduce depressive-like behaviors in mice.

Science signaling·2026

Same author

<i>Strobilanthes danxiaensis</i>, a new species of Acanthaceae endemic to Danxia Mountain in Guangdong Province, China.

PhytoKeys·2025

Same author

Peroxiredoxin 4 as a switch regulating PTEN/AKT axis in alveolar macrophages activation.

Signal transduction and targeted therapy·2025

Same author

Clinical study of aumolertinib versus osimertinib in the treatment of EGFR-mutated advanced non-small cell lung cancer.

Discover oncology·2025

Same author

[Evaluation and Analysis of Carbon Reduction Effect of Domestic Waste Incineration Power Generation].

Huan jing ke xue= Huanjing kexue·2025

Virus-like particles (VLPs) mimic viruses without genetic material, aiding research in virus assembly and morphology. These particles are effective in vaccines, immunology assays, and as delivery vehicles for therapeutic molecules.

Area of Science:

Structural biology
Immunology
Biotechnology

Context:

Virus-like particles (VLPs) are non-infectious agents that resemble native viruses.
VLPs are crucial tools in understanding viral structure and assembly.
Their unique properties make them valuable in various biomedical applications.

Purpose:

To highlight the multifaceted applications of Virus-like Particles (VLPs).
To underscore the role of VLPs in fundamental virology research.
To showcase VLP potential in vaccine development and drug delivery.

Summary:

Virus-like particles (VLPs) structurally mimic authentic viruses but lack viral genomes, making them safe for research and therapeutic use.
VLPs are instrumental in studying virus assembly and morphology diversity.

More Related Videos

Viral Nanoparticles for In vivo Tumor Imaging

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

Advancing High-Resolution Imaging of Virus Assemblies in Liquid and Ice

Advancing High-Resolution Imaging of Virus Assemblies in Liquid and Ice

Published on: July 20, 2022

Related Experiment Videos

Last Updated: Jun 17, 2026

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

Viral Nanoparticles for In vivo Tumor Imaging

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

Advancing High-Resolution Imaging of Virus Assemblies in Liquid and Ice

Advancing High-Resolution Imaging of Virus Assemblies in Liquid and Ice

Published on: July 20, 2022

Their immunological properties enable effective immune response induction and allow for use as adjuvants.

VLPs can be engineered as chimeric vaccines by integrating adjuvants or polypeptides.

Furthermore, VLPs serve as effective delivery vehicles for nucleic acids and other small molecules, and can replace natural viruses in immunological assays.

Impact:

VLPs advance basic virology research, particularly in understanding virus assembly and morphology.
VLPs offer a promising platform for developing novel vaccines and effective immunotherapies.
The versatility of VLPs extends to applications in targeted drug delivery systems.
VLPs contribute to the development of improved immunological assays.